Dear Prescriber,

We write to inform you that Australia will experience a significant shortage in the supply of SINEMET CR starting in early 2010 and continuing into 2011. ... ..it is estimated that initially only 20-50% of patients will be able to receive uninterrupted supply..

We appreciate your management concerns for your patients, especially for those whose symptoms are difficult to control. Your assistance in enabling a limited number of patients to receive continued supply through this difficult period is greatly appreciated.

Notice of the shortage of SINEMET CR is being communicated to neurologists, geriatricians and general practitioners in the first instance. Pharmacies will be informed of the stock shortage in a separate communication

For further information, please contact our Medical Information Department on 1800 645 712.

Dr Troels Wolthers

Medical Director
® Registered Trademark of Merck Sharp & Dohme Corp., a subsidiary of
Merck & Co., Inc., Whitehouse Station, NJ, USA